Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Drops By 21.5%

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) was the target of a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 40,324 shares, a decrease of 21.5% from the January 15th total of 51,341 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 43,196 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily volume of 43,196 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.2% of the shares of the company are sold short.

Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences

Several institutional investors have recently made changes to their positions in the stock. Alberta Investment Management Corp bought a new position in Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter worth about $5,240,000. Meteora Capital LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the second quarter valued at about $517,000. Clear Street LLC lifted its holdings in shares of Oaktree Acquisition Corp. III Life Sciences by 265.1% in the second quarter. Clear Street LLC now owns 22,000 shares of the company’s stock worth $230,000 after buying an additional 15,975 shares in the last quarter. Whitebox Advisors LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at approximately $2,612,000. Finally, JPMorgan Chase & Co. purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the second quarter valued at approximately $2,094,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of OACC traded up $0.05 during trading hours on Monday, hitting $10.63. The company’s stock had a trading volume of 304 shares, compared to its average volume of 27,404. The business has a 50 day simple moving average of $10.62 and a two-hundred day simple moving average of $10.56. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.99 and a 52-week high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.